Preconditioning delays Ca2+-induced mitochondrial permeability transition

Cardiovasc Res. 2004 Jan 1;61(1):115-22. doi: 10.1016/j.cardiores.2003.11.003.

Abstract

Objective: We investigated whether ischemic preconditioning (PC) may modify mitochondrial permeability transition (MPT) pore opening.

Methods: In protocol 1, New Zealand White rabbits underwent either no intervention (sham group) or 10 min of ischemia followed by 5 min of reperfusion, preceded (PC) or not (C; control) by one episode of 5 min of ischemia and 5 min of reperfusion. Rabbits were pretreated by either saline or the MPT pore inhibitor cyclosporin A (CsA), or its non-immunosuppressive derivative Cs29 (10 mg/kg, IV bolus). Hearts were harvested and mitochondria isolated for further assessment of Ca(2+)-induced MPT using a Ca(2+)-sensitive micro-electrode. In protocol 2, C and PC hearts underwent 30 min of ischemia and 4 h of reperfusion. They were pretreated either by saline, CsA or Cs29, as in protocol 1. Infarct size was assessed by triphenyltetrazolium, and apoptosis by TUNEL staining.

Results: In protocol 1, the Ca(2+) overload required to induce MPT pore opening was significantly higher in PC than in C hearts. CsA and Cs29 significantly increased the Ca(2+) overload required for MPT pore opening. In protocol 2, mean infarct size averaged 25% of the risk region in CsA/Cs29 treated hearts versus 15% in PC and 55% in controls (P<0.05 vs. C, P=ns vs. PC). Cardiomyocyte apoptosis was significantly reduced by PC and cyclosporin treatment with a mean apoptotic index of less than 2% in either group versus more than 11% in controls.

Conclusion: This suggests that delayed opening of MPT pore may play a major role in ischemic PC.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Apoptosis
  • Calcium / pharmacology*
  • Cyclosporine / pharmacology
  • Immunosuppressive Agents / pharmacology
  • In Situ Nick-End Labeling
  • Intracellular Membranes / metabolism
  • Ischemic Preconditioning, Myocardial*
  • Male
  • Microscopy, Electron
  • Mitochondria, Heart / drug effects
  • Mitochondria, Heart / metabolism*
  • Myocardial Infarction / metabolism*
  • Myocardial Infarction / pathology
  • Myocytes, Cardiac / pathology
  • Necrosis
  • Permeability / drug effects
  • Rabbits
  • Random Allocation

Substances

  • Immunosuppressive Agents
  • cyclosporin 29
  • Cyclosporine
  • Calcium